Εμφάνιση απλής εγγραφής

dc.creatorBartosova M., Zarogiannis S.G., Schmitt C.P., Arbeiter K., Ariceta G., Bayazit A.K., Büscher R., Caliskan S., Cerkauskiene R., Drozdz D., Fathallah-Shaykh S., Klaus G., Krmar R.T., Oh J., Peters V., Querfeld U., Ranchin B., Sallay P., Schaefer B., Taylan C., Testa S., VandeWalle J., Verrina E., Vondrak K., Warady B.A., Yap Y.C., Zaloszyc A., for the Members of the International Pediatric Peritoneal Biobanken
dc.date.accessioned2023-01-31T07:36:12Z
dc.date.available2023-01-31T07:36:12Z
dc.date.issued2022
dc.identifier10.1186/s40348-022-00141-3
dc.identifier.issn21947791
dc.identifier.urihttp://hdl.handle.net/11615/71141
dc.description.abstractChildren with chronic kidney disease (CKD) suffer from inflammation and reactive metabolite-induced stress, which massively accelerates tissue and vascular aging. Peritoneal dialysis (PD) is the preferred dialysis mode in children, but currently used PD fluids contain far supraphysiological glucose concentrations for fluid and toxin removal and glucose degradation products (GDP). While the peritoneal membrane of children with CKD G5 exhibits only minor alterations, PD fluids trigger numerous molecular cascades resulting in major peritoneal membrane inflammation, hypervascularization, and fibrosis, with distinct molecular and morphological patterns depending on the GDP content of the PD fluid used. PD further aggravates systemic vascular disease. The systemic vascular aging process is particularly pronounced when PD fluids with high GDP concentrations are used. GDP induce endothelial junction disintegration, apoptosis, fibrosis, and intima thickening. This review gives an overview on the molecular mechanisms of peritoneal and vascular transformation and strategies to improve peritoneal and vascular health in patients on PD. © 2022, The Author(s).en
dc.language.isoenen
dc.sourceMolecular and Cellular Pediatricsen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85129798301&doi=10.1186%2fs40348-022-00141-3&partnerID=40&md5=a6d1f76ff0a23cd1006edcf4a8ba1cfd
dc.subjectamino aciden
dc.subjectcarnitineen
dc.subjectglucoseen
dc.subjecticodextrinen
dc.subjectperitoneal dialysis fluiden
dc.subjecttoxinen
dc.subjectabdominal wallen
dc.subjectbiocompatibilityen
dc.subjectbiomembraneen
dc.subjectblood vessel densityen
dc.subjectchilden
dc.subjectchronic kidney failureen
dc.subjectclinical outcomeen
dc.subjectdisease associationen
dc.subjectdisease courseen
dc.subjectendotheliumen
dc.subjectepithelial mesenchymal transitionen
dc.subjectgenome-wide association studyen
dc.subjectglucose transporten
dc.subjecthealth statusen
dc.subjecthumanen
dc.subjectmembrane permeabilityen
dc.subjectmeta analysis (topic)en
dc.subjectmolecular biologyen
dc.subjectperitoneal dialysisen
dc.subjectperitoneal diseaseen
dc.subjectperitoneal fluiden
dc.subjectperitoneumen
dc.subjectReviewen
dc.subjecttreatment indicationen
dc.subjectvascular diseaseen
dc.subjectvascularizationen
dc.subjectSpringer Science and Business Media Deutschland GmbHen
dc.titleHow peritoneal dialysis transforms the peritoneum and vasculature in children with chronic kidney disease—what can we learn for future treatment?en
dc.typeotheren


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής